Mon, August 15, 2022

Yigal Nochomovitz Maintained (UBX) at Strong Buy with Increased Target to $80 on, Aug 15th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-80-on-aug-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Yigal Nochomovitz of Citigroup, Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Increased Target from $50 to $80 on, Aug 15th, 2022.

Yigal, nor any peers, have made any analyst calls on UBX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30